NeOnc Technologies Holdings, Inc.
PublicNeOnc Technologies Holdings, Inc. is now publicly traded
The data on this page reflects NeOnc Technologies Holdings, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series A
Convertible Preferred Stock
Jun 10, 2026
Total Funding Raised
$36.61M
Company Overview
NeOnc Technologies Holdings, Inc. operates in Healthcare and is based in the United States. It has raised $36.61M.
NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company that focuses on the development and commercialization of central nervous system therapeutics designed to overcome the blood-brain barrier.
Sector
Healthcare
AI Layer
Non-AI
NeOnc Technologies Holdings, Inc. Comparables
Compare NeOnc Technologies Holdings, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sollievo Pharmaceuticals, Inc. | 44% |
For institutional investors. Book with your work email.
NeOnc Technologies Holdings, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Convertible Preferred Stock | Jun 10, 2026 | ||||
| Private Placement | Jan 29, 2026 | ||||
| Private Placement | Dec 1, 2025 | ||||
| Private Placement | Mar 26, 2025 | ||||
| Private Placement | Jul 15, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeOnc Technologies Holdings, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.